Molina Healthcare, Inc. (NYSE:MOH) Q2 2024 Earnings Call Transcript July 25, 2024 8:00 AM ET
Company Participants
Joseph Zubretsky - President, Chief Executive Officer
Mark Keim - Chief Financial Officer
Jeffrey Geyer - Head of Investor Relations
Conference Call Participants
A.J. Rice - UBS
Andrew Mok - Barclays
Ryan Langston - TD Cowen
Josh Raskin - Nephron Research
Kevin Fischbeck - Bank of America
Justin Lake - Wolfe Research
Stephen Baxter - Wells Fargo
Sarah James - Cantor Fitzgerald
Michael Hall - Baird
Scott Fidel - Stephens
George Hill - Deutsche Bank
Operator
Good day! And welcome to the Molina Healthcare Second Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions]. After today's presentation there will be an opportunity to ask questions. [Operator Instructions]. Please note this event is being recorded.
I would now like to turn the conference to Jeffrey Geyer, Head of Investor Relations. Please go ahead, sir.
Jeffrey Geyer
Good morning, and welcome to Molina Healthcare's second quarter 2024 earnings call. Joining me today are Molina's President and CEO, Joe Zubretsky; and our CFO, Mark Keim.
A press release announcing our second quarter 2024 earnings was distributed after the market closed yesterday and is available on our Investor Relations website. Shortly after the conclusion of this call, a replay will be available for 30 days. The numbers to access the replay are in the earnings release.
For those of you who listen to the rebroadcast of this presentation, we remind you that, all of the remarks are made as of today, Thursday, July 25, 2024 and has not been updated subsequent to the initial earnings call.
On this call, we will refer to certain non-GAAP measures. A reconciliation of these measures with the most directly comparable GAAP measures can be found in the second quarter 2024 earnings release.
During the call, we will be making certain forward-looking statements, including, but not limited to statements regarding our 2024 guidance, Medicaid redeterminations, expected Medicaid rate adjustments, medical cost initiatives, and our projected MCR, our recent RFP awards and related revenue growth, our acquisitions and M&A activity, our long-term growth strategy, and our embedded earnings power and future earnings realization.
Listeners are cautioned that all of our forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from our current expectations. We advise listeners to review the risk factors discussed in our Form 10-K Annual Report filed with the SEC, as well as our risk factors listed in our Form 10-Q and Form 8-K filings with the SEC. After the completion of our prepared remarks, we will open the call to take your questions.